Steigerwald, Gordon & Koch Inc. Edwards Lifesciences Corp Transaction History
Steigerwald, Gordon & Koch Inc.
- $954 Million
- Q4 2025
A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 368 shares of EW stock, worth $31,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
368
Previous 391
5.88%
Holding current value
$31,758
Previous $30,000
3.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EW
# of Institutions
1,471Shares Held
468MCall Options Held
3.46MPut Options Held
4.07M-
Vanguard Group Inc Valley Forge, PA70.1MShares$6.05 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.4 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.21 Billion0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY25.1MShares$2.16 Billion0.13% of portfolio
-
Wellington Management Group LLP Boston, MA20.8MShares$1.8 Billion0.3% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $53.4B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...